Antimicrobial Drug Consortium Could Speed Resistant Pathogen Trials
Executive Summary
An antimicrobial drug consortium should be established to facilitate the development of drugs for resistant organisms, members of FDA's Anti-Infective Drugs Advisory Committee recommended
You may also be interested in...
Viropharma Picovir Oral Contraceptive Study Data Expected This Summer
Viropharma expects to have data from a Phase I drug interaction study of oral contraceptives and Picovir (pleconaril) in two to four months
Viropharma Picovir Oral Contraceptive Study Data Expected This Summer
Viropharma expects to have data from a Phase I drug interaction study of oral contraceptives and Picovir (pleconaril) in two to four months
Synercid, Zyvox Drug Pricing Discourages Use, IDSA Rep Says
The cost of Aventis' Synercid and Pharmacia's Zyvox discourages use of the drugs for resistant disease pathogens, Infectious Disease Society of America representative Louis Rice, MD, Louis Stokes Cleveland Veterans Affairs Medical Center, told FDA's Anti-Infective Drugs Advisory Committee